Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03056755
Brief Title: Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments (BYLieve)

First Submitted : February 15, 2017
First Submitted that Met QC Criteria : February 15, 2017
First Posted : February 17, 2017

Last Update Submitted that Met QC Criteria : August 1, 2019
Last Update Posted : August 5, 2019